Floatz logo

VALSARTAN

Hypertensive Disorder

University of Alabama at BirminghamSmall moleculePhase 4 / ApprovedActive
BBB
77/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
74/ 100
Competitive Position
81/ 100

Competitive context

32 Active assets in the Hypertensive Disorder cohort.

Asset / SponsorPhaseRating
Hydrochlorothiazide
University of Kansas Medical Center
Phase 4BBB
Losartan
Rong Zhang
Phase 4BBB
AMLODIPINE
Jing Liu
Phase 4BBB
Trandolapril
University of Florida
Phase 4BBB
OLMESARTAN MEDOXOMIL
Virginia Polytechnic Institute and State University
Phase 4BBB

View all 50 →

Same molecule, other indications

VALSARTAN is also rated in:

essential hypertensionActive
BB
Indicative · Phase 4
69 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
BB
Indicative · Phase 4
69 / 100
View asset →
stroke disorderDormant
BB
Indicative · Phase 4
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →